首页> 美国卫生研究院文献>Acta Pharmaceutica Sinica. B >Scutellarin inhibits caspase-11 activation and pyroptosis in macrophages
【2h】

Scutellarin inhibits caspase-11 activation and pyroptosis in macrophages

机译:Scutellarin在巨噬细胞中抑制Caspase-11活化和糊衰分

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Inflammatory caspase-11 senses and is activated by intracellular lipopolysaccharide (LPS) leading to pyroptosis that has critical role in defensing against bacterial infection, whereas its excess activation under pathogenic circumstances may cause various inflammatory diseases. However, there are few known drugs that can control caspase-11 activation. We report here that scutellarin, a flavonoid from Erigeron breviscapus, acted as an inhibitor for caspase-11 activation in macrophages. Scutellarin dose-dependently inhibited intracellular LPS-induced release of caspase-11p26 (indicative of caspase-11 activation) and generation of N-terminal fragment of gasdermin D (GSDMD-NT), leading to reduced pyroptosis. It also suppressed the activation of non-canonical nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3 (NLRP3) inflammasome as evidenced by reduced apoptosis-associated speck-like protein containing a CARD (ASC) speck formation and decreased interleukin-1 beta (IL-1β) and caspase-1p10 secretion, whereas the NLRP3-specific inhibitor MCC950 only inhibited IL-1β and caspase-1p10 release and ASC speck formation but not pyroptosis. Scutellarin also suppressed LPS-induced caspase-11 activation and pyroptosis in RAW 264.7 cells lacking ASC expression. Moreover, scutellarin treatment increased Ser/Thr phosphorylation of caspase-11 at protein kinase A (PKA)-specific sites, and its inhibitory action on caspase-11 activation was largely abrogated by PKA inhibitor H89 or by adenylyl cyclase inhibitor MDL12330A. Collectively, our data indicate that scutellarin inhibited caspase-11 activation and pyroptosis in macrophages at least partly via regulating the PKA signaling pathway.
机译:炎症性胱天蛋白酶-11感测,并通过细胞内脂多糖(LPS)活化,导致糊酶在防御细菌感染方面具有关键作用,而其在致病环境下的过度活化可能会导致各种炎症性疾病。然而,有很少的已知药物可以控制Caspase-11激活。我们在此报告,Scutellarin,来自Erigeron Breviscapus的黄酮类化合物,作为巨噬细胞中Caspase-11活化的抑制剂。 Scutellarin剂量依赖性抑制细胞内LPS诱导的Caspase-11p26(表明Caspase-11激活)和燃气蛋白D(GSDMD-NT)的N-末端片段的产生,导致糊衰低。它还抑制了含有3(NLRP3)炎性的非规范核苷酸结合寡聚吲哚类的受体吡喃结构域的激活,如含有卡(ASC)斑点形成和下白细胞介素-1减少的细胞凋亡相关的斑点蛋白所证明的β(IL-1β)和Caspase-1P10分泌,而NLRP3特异性抑制剂MCC950仅抑制IL-1β和Caspase-1P10释放和ASC斑块形成但不是糊化酶。 Scutellarin还抑制了LPS诱导的Caspase-11在缺乏ASC表达的原始264.7细胞中的活化和糊酶。此外,Scutellarin治疗在蛋白激酶A(PKA)特异性位点上增加了Caspase-11的Ser / Thr磷酸化,并且其对Caspase-11活化的抑制作用在很大程度上,PKA抑制剂H89或腺苷环化酶抑制剂MDL12330A的抑制作用。集体,我们的数据表明,昆霉素至少通过调节PKA信号通路至少部分地抑制巨噬细胞的Caspase-11活化和糊化症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号